Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TKO Group Holdings (TKO) Current Deferred Revenue (2022 - 2025)

TKO Group Holdings' Current Deferred Revenue history spans 4 years, with the latest figure at $545.3 million for Q3 2025.

  • For Q3 2025, Current Deferred Revenue rose 705.38% year-over-year to $545.3 million; the TTM value through Sep 2025 reached $545.3 million, up 705.38%, while the annual FY2024 figure was $416.7 million, 250.19% up from the prior year.
  • Current Deferred Revenue for Q3 2025 was $545.3 million at TKO Group Holdings, up from $439.5 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $545.3 million in Q3 2025 and bottomed at $67.7 million in Q3 2024.
  • The 4-year median for Current Deferred Revenue is $115.4 million (2023), against an average of $242.3 million.
  • The largest annual shift saw Current Deferred Revenue dropped 28.33% in 2024 before it skyrocketed 705.38% in 2025.
  • A 4-year view of Current Deferred Revenue shows it stood at $71.6 million in 2022, then surged by 66.13% to $119.0 million in 2023, then soared by 250.19% to $416.7 million in 2024, then skyrocketed by 30.86% to $545.3 million in 2025.
  • Per Business Quant, the three most recent readings for TKO's Current Deferred Revenue are $545.3 million (Q3 2025), $439.5 million (Q2 2025), and $457.0 million (Q1 2025).